Global Search
0RA9
lse
Abivax SA
Last
$99.40
Vol 24h
684,653.5
Chg 24h
1.79%
LAST UPDATED --
Indicator
5M
15M
1H
4H
1D
RSI
--
--
--
--
--
MFI
--
--
--
--
--
AI Score
--
--
--
--
--
AI Delta
--
--
--
--
--
EMA 12
--
--
--
--
--
EMA 24
--
--
--
--
--
EMA12 Accel
--
--
--
--
--
Simulate entries before committing real capital. Review the ticket, size the order, and execute a paper buy or sell for 0RA9.
Available Balance
Loading...
Last Price
$99.40
Position Size
0 0RA9
Position Value
No position
Trade Ticket
0RA9 / LSE
Qty
USD
Order Quantity
Ticket Summary
Mode: Quantity
Order Value: $99.40
Sellable: No position
You do not currently own 0RA9 on LSE.
Order Value
$99.40
Owned Assets
Loading assets...
Abivax SA is a biotechnology company developing innovative immunotherapies for serious diseases. Focused on cancer, infectious diseases, and autoimmun autoimmune disorders, it leverages expertise in the human immune system to create effective treatments. Listed on the London Stock Exchange (LSE), Abi Abivax aims to improve patient outcomes through its proprietary vaccine and and immunomodulatory approaches.
Watchlist
Focus symbols, live pricing and short-term change
Loading watchlist...
Loading news for 0RA9...
Loading reports for 0RA9...